nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Hoarseness—Sorafenib—liver cancer	0.0342	0.0456	CcSEcCtD
Ipratropium bromide—Dysphonia—Sorafenib—liver cancer	0.0183	0.0244	CcSEcCtD
Ipratropium bromide—Influenza like illness—Sorafenib—liver cancer	0.0146	0.0195	CcSEcCtD
Ipratropium bromide—Local reaction—Epirubicin—liver cancer	0.01	0.0134	CcSEcCtD
Ipratropium bromide—Dysphagia—Sorafenib—liver cancer	0.00944	0.0126	CcSEcCtD
Ipratropium bromide—Local reaction—Doxorubicin—liver cancer	0.00929	0.0124	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Sorafenib—liver cancer	0.00905	0.0121	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Sorafenib—liver cancer	0.00825	0.011	CcSEcCtD
Ipratropium bromide—Stomatitis—Sorafenib—liver cancer	0.0082	0.0109	CcSEcCtD
Ipratropium bromide—Epistaxis—Sorafenib—liver cancer	0.00794	0.0106	CcSEcCtD
Ipratropium bromide—Lung disorder—Epirubicin—liver cancer	0.00786	0.0105	CcSEcCtD
Ipratropium bromide—Haemoglobin—Sorafenib—liver cancer	0.00759	0.0101	CcSEcCtD
Ipratropium bromide—Haemorrhage—Sorafenib—liver cancer	0.00756	0.0101	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Sorafenib—liver cancer	0.00746	0.00995	CcSEcCtD
Ipratropium bromide—Urethral disorder—Sorafenib—liver cancer	0.00741	0.00988	CcSEcCtD
Ipratropium bromide—Lung disorder—Doxorubicin—liver cancer	0.00727	0.00969	CcSEcCtD
Ipratropium bromide—Tinnitus—Sorafenib—liver cancer	0.00704	0.0094	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Sorafenib—liver cancer	0.00701	0.00935	CcSEcCtD
Ipratropium bromide—Flushing—Sorafenib—liver cancer	0.00701	0.00935	CcSEcCtD
Ipratropium bromide—Immune system disorder—Sorafenib—liver cancer	0.00682	0.0091	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Sorafenib—liver cancer	0.00681	0.00908	CcSEcCtD
Ipratropium bromide—Dysphonia—Epirubicin—liver cancer	0.00676	0.00901	CcSEcCtD
Ipratropium bromide—Dysgeusia—Sorafenib—liver cancer	0.00644	0.00859	CcSEcCtD
Ipratropium bromide—Cardiovascular disorder—Epirubicin—liver cancer	0.00633	0.00844	CcSEcCtD
Ipratropium bromide—Dysphonia—Doxorubicin—liver cancer	0.00625	0.00834	CcSEcCtD
Ipratropium bromide—Angioedema—Sorafenib—liver cancer	0.00601	0.00802	CcSEcCtD
Ipratropium bromide—Ulcer—Epirubicin—liver cancer	0.00588	0.00784	CcSEcCtD
Ipratropium bromide—Cardiovascular disorder—Doxorubicin—liver cancer	0.00586	0.00781	CcSEcCtD
Ipratropium bromide—Cough—Sorafenib—liver cancer	0.00574	0.00765	CcSEcCtD
Ipratropium bromide—Inflammation—Epirubicin—liver cancer	0.00573	0.00765	CcSEcCtD
Ipratropium bromide—Hypertension—Sorafenib—liver cancer	0.00568	0.00757	CcSEcCtD
Ipratropium bromide—Myalgia—Sorafenib—liver cancer	0.0056	0.00747	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00556	0.00742	CcSEcCtD
Ipratropium bromide—Dry mouth—Sorafenib—liver cancer	0.00548	0.0073	CcSEcCtD
Ipratropium bromide—Ulcer—Doxorubicin—liver cancer	0.00544	0.00725	CcSEcCtD
Ipratropium bromide—Influenza like illness—Epirubicin—liver cancer	0.0054	0.0072	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Epirubicin—liver cancer	0.0054	0.0072	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Sorafenib—liver cancer	0.00537	0.00716	CcSEcCtD
Ipratropium bromide—Infection—Sorafenib—liver cancer	0.00533	0.00711	CcSEcCtD
Ipratropium bromide—Inflammation—Doxorubicin—liver cancer	0.0053	0.00707	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Sorafenib—liver cancer	0.00526	0.00702	CcSEcCtD
Ipratropium bromide—Skin disorder—Sorafenib—liver cancer	0.00521	0.00695	CcSEcCtD
Ipratropium bromide—Influenza like illness—Doxorubicin—liver cancer	0.005	0.00666	CcSEcCtD
Ipratropium bromide—Salivary hypersecretion—Doxorubicin—liver cancer	0.005	0.00666	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00489	0.00652	CcSEcCtD
Ipratropium bromide—Abnormal vision—Epirubicin—liver cancer	0.00485	0.00647	CcSEcCtD
Ipratropium bromide—Dyspnoea—Sorafenib—liver cancer	0.00479	0.00638	CcSEcCtD
Ipratropium bromide—Dyspepsia—Sorafenib—liver cancer	0.00473	0.0063	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Sorafenib—liver cancer	0.00463	0.00618	CcSEcCtD
Ipratropium bromide—Fatigue—Sorafenib—liver cancer	0.00463	0.00617	CcSEcCtD
Ipratropium bromide—Pain—Sorafenib—liver cancer	0.00459	0.00612	CcSEcCtD
Ipratropium bromide—Constipation—Sorafenib—liver cancer	0.00459	0.00612	CcSEcCtD
Ipratropium bromide—Abnormal vision—Doxorubicin—liver cancer	0.00449	0.00598	CcSEcCtD
Ipratropium bromide—Eye pain—Epirubicin—liver cancer	0.00447	0.00596	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Sorafenib—liver cancer	0.00439	0.00585	CcSEcCtD
Ipratropium bromide—Urticaria—Sorafenib—liver cancer	0.00426	0.00569	CcSEcCtD
Ipratropium bromide—Abdominal pain—Sorafenib—liver cancer	0.00424	0.00566	CcSEcCtD
Ipratropium bromide—Eye pain—Doxorubicin—liver cancer	0.00414	0.00552	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Sorafenib—liver cancer	0.00395	0.00527	CcSEcCtD
Ipratropium bromide—Asthenia—Sorafenib—liver cancer	0.00385	0.00514	CcSEcCtD
Ipratropium bromide—Pruritus—Sorafenib—liver cancer	0.0038	0.00507	CcSEcCtD
Ipratropium bromide—Diarrhoea—Sorafenib—liver cancer	0.00367	0.0049	CcSEcCtD
Ipratropium bromide—Dizziness—Sorafenib—liver cancer	0.00355	0.00473	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—liver cancer	0.00349	0.00465	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—liver cancer	0.00349	0.00465	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—liver cancer	0.00349	0.00465	CcSEcCtD
Ipratropium bromide—Vomiting—Sorafenib—liver cancer	0.00341	0.00455	CcSEcCtD
Ipratropium bromide—Rash—Sorafenib—liver cancer	0.00338	0.00451	CcSEcCtD
Ipratropium bromide—Dermatitis—Sorafenib—liver cancer	0.00338	0.00451	CcSEcCtD
Ipratropium bromide—Headache—Sorafenib—liver cancer	0.00336	0.00449	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—liver cancer	0.00336	0.00447	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—liver cancer	0.00326	0.00435	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—liver cancer	0.00324	0.00432	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—liver cancer	0.00323	0.00431	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—liver cancer	0.00323	0.00431	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—liver cancer	0.00323	0.00431	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—liver cancer	0.00322	0.0043	CcSEcCtD
Ipratropium bromide—Nausea—Sorafenib—liver cancer	0.00319	0.00425	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—liver cancer	0.0031	0.00414	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—liver cancer	0.00305	0.00407	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—liver cancer	0.00303	0.00404	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—liver cancer	0.00302	0.00403	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—liver cancer	0.00302	0.00403	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—liver cancer	0.00302	0.00403	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—liver cancer	0.003	0.004	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—liver cancer	0.00298	0.00398	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—liver cancer	0.00298	0.00398	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—liver cancer	0.00293	0.00391	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—liver cancer	0.00292	0.00389	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—liver cancer	0.00282	0.00376	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—liver cancer	0.00281	0.00374	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—liver cancer	0.00281	0.00374	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—liver cancer	0.0028	0.00373	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—liver cancer	0.0028	0.00373	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—liver cancer	0.0028	0.00373	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—liver cancer	0.00279	0.00372	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—liver cancer	0.00278	0.00371	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—liver cancer	0.00277	0.0037	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—liver cancer	0.00276	0.00368	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—liver cancer	0.00276	0.00368	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—liver cancer	0.00274	0.00365	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—liver cancer	0.00271	0.00362	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—liver cancer	0.0027	0.0036	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—liver cancer	0.00269	0.00359	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—liver cancer	0.00261	0.00348	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—liver cancer	0.0026	0.00347	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—liver cancer	0.0026	0.00346	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—liver cancer	0.00259	0.00346	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—liver cancer	0.00259	0.00346	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—liver cancer	0.00259	0.00345	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—liver cancer	0.00258	0.00345	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—liver cancer	0.00257	0.00343	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—liver cancer	0.00256	0.00342	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—liver cancer	0.00255	0.0034	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—liver cancer	0.00253	0.00338	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—liver cancer	0.00252	0.00336	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—liver cancer	0.00252	0.00336	CcSEcCtD
Ipratropium bromide—Visual impairment—Doxorubicin—liver cancer	0.00249	0.00332	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—liver cancer	0.00241	0.00322	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—liver cancer	0.00241	0.00321	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—liver cancer	0.0024	0.0032	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—liver cancer	0.0024	0.0032	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—liver cancer	0.0024	0.00319	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—liver cancer	0.00239	0.00318	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—liver cancer	0.00238	0.00317	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—liver cancer	0.00236	0.00315	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—liver cancer	0.00235	0.00314	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—liver cancer	0.00233	0.00311	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—liver cancer	0.00233	0.00311	CcSEcCtD
Ipratropium bromide—Vision blurred—Epirubicin—liver cancer	0.00229	0.00306	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—liver cancer	0.00222	0.00296	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—liver cancer	0.00221	0.00294	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—liver cancer	0.0022	0.00294	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—liver cancer	0.00218	0.00291	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—liver cancer	0.00218	0.0029	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—liver cancer	0.00215	0.00286	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—liver cancer	0.00212	0.00283	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—liver cancer	0.00212	0.00283	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—liver cancer	0.0021	0.0028	CcSEcCtD
Ipratropium bromide—Chest pain—Epirubicin—liver cancer	0.00207	0.00276	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—liver cancer	0.00207	0.00276	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00206	0.00274	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—liver cancer	0.00202	0.0027	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—liver cancer	0.00199	0.00265	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—liver cancer	0.00198	0.00265	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—liver cancer	0.00198	0.00265	CcSEcCtD
Ipratropium bromide—Infection—Epirubicin—liver cancer	0.00197	0.00263	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—liver cancer	0.00196	0.00262	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—liver cancer	0.00195	0.00259	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—liver cancer	0.00194	0.00259	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—liver cancer	0.00194	0.00258	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—liver cancer	0.00193	0.00257	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—liver cancer	0.00192	0.00256	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—liver cancer	0.00191	0.00255	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—liver cancer	0.00191	0.00255	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0019	0.00254	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—liver cancer	0.00187	0.0025	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—liver cancer	0.00185	0.00247	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—liver cancer	0.00184	0.00245	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—liver cancer	0.00184	0.00245	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—liver cancer	0.00182	0.00243	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00181	0.00241	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—liver cancer	0.0018	0.0024	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—liver cancer	0.00179	0.00239	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—liver cancer	0.00179	0.00239	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—liver cancer	0.00178	0.00238	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—liver cancer	0.00178	0.00238	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—liver cancer	0.00177	0.00237	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—liver cancer	0.00177	0.00236	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—liver cancer	0.00176	0.00235	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—liver cancer	0.00175	0.00233	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—liver cancer	0.00172	0.00229	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—liver cancer	0.00171	0.00228	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—liver cancer	0.00171	0.00228	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—liver cancer	0.0017	0.00226	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—liver cancer	0.0017	0.00226	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00167	0.00223	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—liver cancer	0.00166	0.00221	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—liver cancer	0.00165	0.0022	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—liver cancer	0.00164	0.00218	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—liver cancer	0.00163	0.00218	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—liver cancer	0.00162	0.00216	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—liver cancer	0.00162	0.00216	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00158	0.00211	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—liver cancer	0.00158	0.00211	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—liver cancer	0.00158	0.0021	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—liver cancer	0.00157	0.00209	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—liver cancer	0.00157	0.00209	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—liver cancer	0.00157	0.00209	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—liver cancer	0.0015	0.002	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—liver cancer	0.00146	0.00195	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—liver cancer	0.00146	0.00194	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—liver cancer	0.00145	0.00194	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—liver cancer	0.00142	0.0019	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—liver cancer	0.0014	0.00187	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—liver cancer	0.00136	0.00181	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Doxorubicin—liver cancer	0.00135	0.0018	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—liver cancer	0.00132	0.00176	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—liver cancer	0.00131	0.00175	CcSEcCtD
Ipratropium bromide—Pruritus—Doxorubicin—liver cancer	0.0013	0.00173	CcSEcCtD
Ipratropium bromide—Vomiting—Epirubicin—liver cancer	0.00126	0.00168	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—liver cancer	0.00126	0.00168	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—liver cancer	0.00124	0.00166	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—liver cancer	0.00121	0.00162	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—liver cancer	0.00118	0.00157	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—liver cancer	0.00117	0.00156	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—liver cancer	0.00116	0.00154	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—liver cancer	0.00116	0.00154	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—liver cancer	0.00115	0.00153	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—liver cancer	0.00109	0.00145	CcSEcCtD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CD—liver cancer	9.02e-05	0.00036	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	8.93e-05	0.000357	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTM1—liver cancer	8.86e-05	0.000354	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CPT1B—liver cancer	8.7e-05	0.000348	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GLUL—liver cancer	8.7e-05	0.000348	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HPGDS—liver cancer	8.58e-05	0.000343	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KDR—liver cancer	8.51e-05	0.00034	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK14—liver cancer	8.46e-05	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP1A1—liver cancer	8.4e-05	0.000336	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NR1H4—liver cancer	8.39e-05	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCE—liver cancer	8.31e-05	0.000332	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ESR1—liver cancer	8.3e-05	0.000332	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCE—liver cancer	8.28e-05	0.000331	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTA3—liver cancer	8.25e-05	0.00033	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	8.22e-05	0.000328	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCE—liver cancer	8.2e-05	0.000328	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—F2—liver cancer	8.19e-05	0.000327	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	8.19e-05	0.000327	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	8.11e-05	0.000324	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	7.89e-05	0.000315	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF2—liver cancer	7.87e-05	0.000315	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	7.86e-05	0.000314	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF2—liver cancer	7.85e-05	0.000314	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CG—liver cancer	7.84e-05	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APC—liver cancer	7.84e-05	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTHFR—liver cancer	7.83e-05	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	7.78e-05	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF2—liver cancer	7.77e-05	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARA—liver cancer	7.69e-05	0.000307	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSMA4—liver cancer	7.65e-05	0.000306	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PSMD10—liver cancer	7.65e-05	0.000306	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTA4—liver cancer	7.55e-05	0.000302	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GOT2—liver cancer	7.44e-05	0.000297	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—BRAF—liver cancer	7.37e-05	0.000295	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTA2—liver cancer	7.35e-05	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CSF2—liver cancer	7.35e-05	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—RAF1—liver cancer	7.34e-05	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CSF2—liver cancer	7.33e-05	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—RAF1—liver cancer	7.31e-05	0.000292	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CSF2—liver cancer	7.26e-05	0.00029	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—H2AFX—liver cancer	7.25e-05	0.00029	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL2—liver cancer	7.24e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—RAF1—liver cancer	7.24e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—H2AFX—liver cancer	7.22e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL2—liver cancer	7.22e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	7.16e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—H2AFX—liver cancer	7.15e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL2—liver cancer	7.15e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	7.14e-05	0.000285	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTA1—liver cancer	7.1e-05	0.000284	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	7.07e-05	0.000283	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NAT2—liver cancer	7.02e-05	0.00028	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP2E1—liver cancer	6.99e-05	0.00028	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CD—liver cancer	6.89e-05	0.000276	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—PIK3CA—liver cancer	6.83e-05	0.000273	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—liver cancer	6.82e-05	0.000272	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—KRAS—liver cancer	6.75e-05	0.00027	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDOB—liver cancer	6.73e-05	0.000269	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CG—liver cancer	6.58e-05	0.000263	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL2—liver cancer	6.58e-05	0.000263	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL2—liver cancer	6.56e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TERT—liver cancer	6.55e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYCS—liver cancer	6.54e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TERT—liver cancer	6.53e-05	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL2—liver cancer	6.49e-05	0.000259	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TERT—liver cancer	6.47e-05	0.000259	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GGT1—liver cancer	6.42e-05	0.000257	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GOT1—liver cancer	6.42e-05	0.000257	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CRABP1—liver cancer	6.42e-05	0.000256	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—liver cancer	6.35e-05	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	6.2e-05	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAF1—liver cancer	6.15e-05	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CB—liver cancer	6.01e-05	0.00024	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MTOR—liver cancer	6.01e-05	0.00024	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KDR—liver cancer	5.99e-05	0.00024	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KDR—liver cancer	5.97e-05	0.000239	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK14—liver cancer	5.95e-05	0.000238	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK14—liver cancer	5.93e-05	0.000237	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KDR—liver cancer	5.92e-05	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK14—liver cancer	5.88e-05	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ESR1—liver cancer	5.84e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ESR1—liver cancer	5.82e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CD—liver cancer	5.79e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—F2—liver cancer	5.77e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTP1—liver cancer	5.77e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ESR1—liver cancer	5.77e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—F2—liver cancer	5.75e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HRAS—liver cancer	5.74e-05	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—liver cancer	5.71e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—F2—liver cancer	5.69e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—liver cancer	5.69e-05	0.000227	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CDKN1B—liver cancer	5.64e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HPGDS—liver cancer	5.61e-05	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—liver cancer	5.58e-05	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CASP3—liver cancer	5.53e-05	0.000221	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APC—liver cancer	5.52e-05	0.000221	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CG—liver cancer	5.52e-05	0.000221	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL2—liver cancer	5.52e-05	0.000221	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CG—liver cancer	5.5e-05	0.00022	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APC—liver cancer	5.5e-05	0.00022	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—liver cancer	5.49e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CG—liver cancer	5.45e-05	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APC—liver cancer	5.45e-05	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCND1—liver cancer	5.38e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—JUN—liver cancer	5.37e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CTNNB1—liver cancer	5.33e-05	0.000213	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—liver cancer	5.3e-05	0.000212	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—liver cancer	5.22e-05	0.000209	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CDKN1A—liver cancer	5.2e-05	0.000208	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—BRAF—liver cancer	5.19e-05	0.000207	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—BRAF—liver cancer	5.17e-05	0.000207	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—BRAF—liver cancer	5.12e-05	0.000205	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK8—liver cancer	5.08e-05	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—liver cancer	5.07e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CB—liver cancer	5.04e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1A1—liver cancer	5.02e-05	0.000201	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMD10—liver cancer	5e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PSMA4—liver cancer	5e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GOT2—liver cancer	4.86e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CD—liver cancer	4.85e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CD—liver cancer	4.84e-05	0.000193	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	4.81e-05	0.000192	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—liver cancer	4.8e-05	0.000192	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	4.79e-05	0.000192	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CD—liver cancer	4.79e-05	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—liver cancer	4.79e-05	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—KRAS—liver cancer	4.75e-05	0.00019	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	4.75e-05	0.00019	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—liver cancer	4.74e-05	0.000189	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—KRAS—liver cancer	4.74e-05	0.000189	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—KRAS—liver cancer	4.69e-05	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—liver cancer	4.69e-05	0.000187	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—liver cancer	4.68e-05	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STAT3—liver cancer	4.64e-05	0.000186	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARA—liver cancer	4.6e-05	0.000184	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP2E1—liver cancer	4.57e-05	0.000183	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	4.37e-05	0.000174	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	4.35e-05	0.000174	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAF1—liver cancer	4.33e-05	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAF1—liver cancer	4.32e-05	0.000173	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—liver cancer	4.31e-05	0.000172	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	4.31e-05	0.000172	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—liver cancer	4.3e-05	0.000172	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYCS—liver cancer	4.28e-05	0.000171	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAF1—liver cancer	4.28e-05	0.000171	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CB—liver cancer	4.23e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MTOR—liver cancer	4.23e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MTOR—liver cancer	4.22e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CB—liver cancer	4.22e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GGT1—liver cancer	4.2e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GOT1—liver cancer	4.2e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MTOR—liver cancer	4.18e-05	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CB—liver cancer	4.18e-05	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HRAS—liver cancer	4.04e-05	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HRAS—liver cancer	4.03e-05	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HRAS—liver cancer	3.99e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KRAS—liver cancer	3.99e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN1B—liver cancer	3.97e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN1B—liver cancer	3.96e-05	0.000158	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CG—liver cancer	3.94e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—liver cancer	3.93e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN1B—liver cancer	3.92e-05	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—liver cancer	3.91e-05	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CASP3—liver cancer	3.89e-05	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL2—liver cancer	3.89e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CASP3—liver cancer	3.88e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—liver cancer	3.88e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL2—liver cancer	3.87e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—liver cancer	3.87e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—liver cancer	3.85e-05	0.000154	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CASP3—liver cancer	3.84e-05	0.000154	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL2—liver cancer	3.84e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—liver cancer	3.82e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—liver cancer	3.8e-05	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCND1—liver cancer	3.79e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—JUN—liver cancer	3.78e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCND1—liver cancer	3.78e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTP1—liver cancer	3.77e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—JUN—liver cancer	3.77e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CTNNB1—liver cancer	3.75e-05	0.00015	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CTNNB1—liver cancer	3.74e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCND1—liver cancer	3.74e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—JUN—liver cancer	3.73e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—liver cancer	3.72e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CTNNB1—liver cancer	3.7e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—liver cancer	3.68e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—liver cancer	3.67e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CDKN1A—liver cancer	3.66e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CA—liver cancer	3.66e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CDKN1A—liver cancer	3.65e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—liver cancer	3.63e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CDKN1A—liver cancer	3.62e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK8—liver cancer	3.58e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—liver cancer	3.57e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK8—liver cancer	3.56e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—liver cancer	3.55e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TP53—liver cancer	3.54e-05	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK8—liver cancer	3.53e-05	0.000141	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—liver cancer	3.52e-05	0.000141	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—liver cancer	3.47e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CD—liver cancer	3.46e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—liver cancer	3.42e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HRAS—liver cancer	3.39e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—liver cancer	3.3e-05	0.000132	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—liver cancer	3.29e-05	0.000132	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1A1—liver cancer	3.28e-05	0.000131	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STAT3—liver cancer	3.27e-05	0.000131	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—liver cancer	3.26e-05	0.00013	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STAT3—liver cancer	3.26e-05	0.00013	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—liver cancer	3.24e-05	0.00013	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STAT3—liver cancer	3.23e-05	0.000129	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CA—liver cancer	3.07e-05	0.000123	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—liver cancer	3.06e-05	0.000122	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—liver cancer	3.04e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—liver cancer	3.03e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—liver cancer	3.03e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—liver cancer	3.02e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CB—liver cancer	3.02e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARA—liver cancer	3e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—liver cancer	3e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—liver cancer	2.99e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.99e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KRAS—liver cancer	2.81e-05	0.000112	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KRAS—liver cancer	2.8e-05	0.000112	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KRAS—liver cancer	2.77e-05	0.000111	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CA—liver cancer	2.58e-05	0.000103	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CG—liver cancer	2.57e-05	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CA—liver cancer	2.57e-05	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.55e-05	0.000102	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—liver cancer	2.51e-05	0.0001	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TP53—liver cancer	2.49e-05	9.97e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TP53—liver cancer	2.49e-05	9.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—liver cancer	2.48e-05	9.93e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TP53—liver cancer	2.46e-05	9.84e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HRAS—liver cancer	2.39e-05	9.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HRAS—liver cancer	2.38e-05	9.51e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HRAS—liver cancer	2.36e-05	9.41e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—liver cancer	2.28e-05	9.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—liver cancer	2.28e-05	9.1e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CD—liver cancer	2.26e-05	9.04e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—liver cancer	2.25e-05	9.01e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—liver cancer	2.23e-05	8.92e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—liver cancer	2.11e-05	8.42e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—liver cancer	2.1e-05	8.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—liver cancer	2.08e-05	8.31e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CB—liver cancer	1.97e-05	7.88e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CA—liver cancer	1.84e-05	7.35e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—liver cancer	1.5e-05	6e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CA—liver cancer	1.2e-05	4.8e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—liver cancer	9.82e-06	3.92e-05	CbGpPWpGaD
